Home/Bendalis/Dr. Dirk Hütten
DD

Dr. Dirk Hütten

Managing Director

Bendalis

Bendalis Pipeline

DrugIndicationPhase
Portfolio Expansion (Generics)Various Oncology IndicationsCommercial
Distribution Partnerships (e.g., Somatostatin Lyomark)Oncology/Supportive CareCommercial
Clinical Trial Supply (Inceptua Partnership)Oncology (Clinical Trials)Commercial Service